Skip to Content

Procyon Corp PCYN Stock Quote

| Rating as of


Last close prices updated as of Jan 09, 2023, 11:28 AM EST | USD
  • Last Close 0.27
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range 0.27  –  0.27
  • Year Range 0.20  –  0.55
  • Market Cap 2.1836 Mil
  • Volume / Avg 2,543.0 /  5,732.9
  • Price / Sales 0.45
  • Price / Book 0.86
  • Forward Div Yield 5.49%
  • Trailing Div Yield

Morningstar‘s Stock Analysis PCYN

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics PCYN

Company Profile PCYN

Business Description

Procyon Corp is a United based company, through its subsidiary, is engaged in developing and marketing proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies and to physicians and other healthcare practitioners. The product lines of the firm are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets the products primarily in the United States.

164 Douglas Road
Oldsmar, FL, 34677
Industry Drug Manufacturers - Specialty & Generic
Employees 19

FAQs for Procyon Corp Stock

Yes. PCYN has a forward dividend yield of 5.49%. See PCYN’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

PCYN’s market cap is 2.18 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

PCYN’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare PCYN’s historical performance against its industry peers and the overall market.